These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 4729848)

  • 21. [Effect of novocainamide on the course of experimental myocardial infarct with arrhythmias in rabbits].
    Marshutina NV
    Farmakol Toksikol; 1980; 43(1):55-9. PubMed ID: 7379992
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The control of cardiac arrhythmias: discussion.
    Ir J Med Sci; 1973 May; 142(3 Suppl):42-50. PubMed ID: 4723016
    [No Abstract]   [Full Text] [Related]  

  • 23. Experiences on a sustained-release procainamide preparation.
    Ruosteenoja R; Torsti P; Sothmann A
    Curr Ther Res Clin Exp; 1973 Oct; 15(10):707-12. PubMed ID: 4201315
    [No Abstract]   [Full Text] [Related]  

  • 24. Early treatment of acute myocardial infarction.
    Becker LC
    Am Fam Physician; 1972 Oct; 6(4):120-8. PubMed ID: 5079757
    [No Abstract]   [Full Text] [Related]  

  • 25. Arrhythmias in myocardial infarction.
    DeSanctis RW
    Del Med J; 1971 Aug; 43(8):209-15. PubMed ID: 5094607
    [No Abstract]   [Full Text] [Related]  

  • 26. Antiarrhythmic prophylaxis in acute myocardial infarction.
    Brooks N; Koch-Weser J
    N Engl J Med; 1971 Apr; 284(15):852. PubMed ID: 5549811
    [No Abstract]   [Full Text] [Related]  

  • 27. Prophylaxis of dysrhythmias after myocardial infarction.
    Br Med J; 1970 Mar; 1(5697):646. PubMed ID: 5443964
    [No Abstract]   [Full Text] [Related]  

  • 28. Letter: Time-dependent effect of oral procainamide in patients with exertional arrhythmias.
    Levy RH; Gey GO; Bruce RA
    J Pharm Sci; 1974 Dec; 63(12):1958-9. PubMed ID: 4449032
    [No Abstract]   [Full Text] [Related]  

  • 29. Symposium on arteriosclerotic heart disease. Tachyarrhythmias. Differential diagnosis and therapy after acute myocardial infarction.
    Rubins S; Lozano J; Carrasco H; Lang TW; Corday E
    Geriatrics; 1972 May; 27(5):123-33. PubMed ID: 5022803
    [No Abstract]   [Full Text] [Related]  

  • 30. Ventricular fibrillation and myocardial necrosis after transient ischemia. Effect of treatment with oxygen, procainamide, reserpine, and propranolol.
    Sommers HM; Jennings RB
    Arch Intern Med; 1972 May; 129(5):780-9. PubMed ID: 5025900
    [No Abstract]   [Full Text] [Related]  

  • 31. [Arrhythmia prophylaxis with procanamide: inadequate dosage?].
    Collste P; Karlsson E; Norlander B; Sievers J; Sjöqvist F
    Lakartidningen; 1972 Jun; 69():Suppl 2:47-50. PubMed ID: 4645697
    [No Abstract]   [Full Text] [Related]  

  • 32. Sustained release procainamide in patients with myocardial infarction.
    Birkhead J; Evans T; Mumford P; Martinez E; Jewitt D
    Br Heart J; 1976 Jan; 38(1):77-80. PubMed ID: 1252299
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinical and pharmacological aspects of the treatment of cardia infarcts].
    Jounela A
    Duodecim; 1977; 93(2):153-61. PubMed ID: 852433
    [No Abstract]   [Full Text] [Related]  

  • 34. Selected topics in cardiac arrhythmias.
    Perloff D; Sokolow M
    Geriatrics; 1967 Sep; 22(9):190-8. PubMed ID: 6033214
    [No Abstract]   [Full Text] [Related]  

  • 35. Procainamide, oxprenolol and amiodarone as antidysrhythmic drugs in myocardial infarction.
    Tuna JL; Correia MJ; d'Almeida VC; Mourão L; da Costa FL; Ribeiro C
    Acta Med Port; 1980 Dec; Suppl 1():27-32. PubMed ID: 6164252
    [No Abstract]   [Full Text] [Related]  

  • 36. A new sustained-release tablet formulation of procainamide.
    Fremstad D; Dahl S; Jacobsen S; Lunde PK; Nådland KJ; Marthinsen AA; Waaler T; Landmark KH
    Eur J Clin Pharmacol; 1973 Dec; 6(4):251-5. PubMed ID: 4591152
    [No Abstract]   [Full Text] [Related]  

  • 37. Plasma concentration of procainamide and prevalence of exertional arrhythmias.
    Gey GO; Levy RH; Fisher L; Pettet G; Bruce RA
    Ann Intern Med; 1974 Jun; 80(6):718-22. PubMed ID: 4832159
    [No Abstract]   [Full Text] [Related]  

  • 38. [Therapy of acute myocardial infarct with particular reference to arrhythmia and myocardial contractibility disorders].
    Robelli F; De Vita C; Cadel A
    G Gerontol; 1971 Jan; 19(1):62-71. PubMed ID: 5567873
    [No Abstract]   [Full Text] [Related]  

  • 39. Comparison of drugs used in management of arrhythmias developing after acute myocardial infarction.
    Jewitt DE; Mercer CJ; Hubner PJ; Shillingford JP
    Br Heart J; 1969 Nov; 31(6):794. PubMed ID: 5358169
    [No Abstract]   [Full Text] [Related]  

  • 40. [Possibilities of drug therapy of arrhythmias in myocardial infarct].
    Kozená J; Kolár J
    Cas Lek Cesk; 1971 May; 110(19):437-41. PubMed ID: 5574742
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.